Ergoteles’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-119,967
Closed -$300K 1464
2022
Q4
$300K Sell
119,967
-13,985
-10% -$35K 0.01% 909
2022
Q3
$565K Buy
+133,952
New +$565K 0.02% 710
2022
Q1
Sell
-100,229
Closed -$915K 1394
2021
Q4
$915K Buy
100,229
+70,344
+235% +$642K 0.04% 439
2021
Q3
$319K Buy
+29,885
New +$319K 0.01% 772